SHS
Spencer Health Solutions Releases New Version of spencerAssist™ Mobile Application
Spencer Health Solutions (SHS) announced today the release of an updated version of its mobile application, spencerAssist™ , as part of the spencer® platform supporting chronic care management patients, clinical trial patients, and patients taking approved specialty medications.
- Spencer Health Solutions (SHS) announced today the release of an updated version of its mobile application, spencerAssist™ , as part of the spencer® platform supporting chronic care management patients, clinical trial patients, and patients taking approved specialty medications.
- This new mobile application is adjunctive to the spencer SmartHub™, an intelligent medication dispenser that promotes near-perfect medication adherence, collects longitudinal real-world data, and engages patients over long periods of time.
- “The new spencerAssist mobile application provides an extra level of support to patients struggling with chronic conditions and those participating in clinical trials, as well as their caregivers,” said Tom Rhoads, founder and chief executive officer of Spencer Health Solutions.
- The spencer platform collects longitudinal insights from patients that can be leveraged to generate patient interventional support strategies while promoting positive health behaviors.
The Eurosystem Integrated Reporting Framework ‒ an overview
The Eurosystem Integrated
- The Eurosystem Integrated
Reporting Framework ? an overview
1Background
European Union (EU) banks face a whole range of data reporting obligations,
including for statistical, resolution and prudential information. - Existing ECB statistical regulations specify the information that must be reported, but
not how the actual reporting process is to be carried out. - The Eurosystem Integrated Reporting Framework ? an overview
1
submitted by reporting agents to NCBs.
- This arrangement dates back to when the ECB was set up in 1998 and was justified
at the time, as it meant that statistical reporting could be founded on well-established
national reporting frameworks. - Figure 1
Current Eurosystem approach to collecting statistical information from banksBanks
NCBs
ECB
Transformations by banks
Transformations by NCBs
Country ABSI & MIR
Integrated approach
?SHS
Country B
Operational
systemsMonetary data
b.o.p., i.i.p &
sector accountsCredit register
Sector accountsAnaCredit
b.o.p. - Under the new paradigm, cross-border banks could unify the
technical specifications of their reporting for all their European entities. - 2
The scope of the IReF
The IReF seeks to integrate existing ESCB statistical data requirements for banks as
far as possible into a single, standardised reporting framework applicable across the
euro area. - The feasibility of aligning the IReF
more closely with the Financial Reporting (FINREP) requirements applicable at solo
level11 is also being assessed. - Some NCBs have
developed an integrated reporting framework for investment funds (covering both
MMFs and non-MMFs). - The Eurosystem reviewed the results of the CBA to identify optimal features for
banks, the Eurosystem and its users. - This time frame will give reporting agents and the Eurosystem enough lead time to
prepare the legal and technical framework without unduly delaying the expected
reduction in the reporting burden. - 16
See ?On a Feasibility Study of an Integrated Reporting System under Article 430c CRR?, EBA, 2021;
and ?The EBA?s feasibility study on integrated reporting system provides a long-term vision for
increasing efficiencies and reducing reporting costs?, EBA, December 2021. - The Eurosystem is already cooperating closely with the banking industry to optimise
reporting and reduce the overall reporting burden via the Banks? Integrated Reporting
Dictionary (BIRD).19 BIRD offers a redundancy-free source (i.e. - The IReF describes statistical requirements in a redundancy-free layer
and will represent future statistical reporting obligations issued by the ECB and
applicable to Eurosystem banks. - Data quality should increase and costs decrease, as the BIRD input layer would
provide a comprehensive and flexible tool to support data reporting.
SHS - Stahl-Holding-Saar Selects Ivalua to Digitize and Streamline Direct and Indirect Source-to-Pay Processes
In need of a robust, yet flexible solution to streamline its procurement operations, SHS selected Ivalua to automate processes and curb maverick spend.
- In need of a robust, yet flexible solution to streamline its procurement operations, SHS selected Ivalua to automate processes and curb maverick spend.
- The partnership will empower SHS to digitize and automate S2P processes resulting in greater efficiency and better control over its supply chain operations.
- "The ongoing commitment and expertise demonstrated by the Ivalua team were instrumental during the selection process," said Markus Lauer, CFO and CPO from SHS.
- "OptiBuy is proud to contribute our expertise to this procurement transformation project at SHS," stated Tomasz Gonsior, Senior Director at OptiBuy.
Marco Paul Named Winner of Best Online Business Award at Scotlands Business Awards 2023
Edinburgh, United Kingdom--(Newsfile Corp. - November 10, 2023) - Marco Paul, the new standard in indoor and outdoor interiors, today announces that it has won the Best Online Business Award at the premier Scotlands Business Awards 2023.
- Edinburgh, United Kingdom--(Newsfile Corp. - November 10, 2023) - Marco Paul, the new standard in indoor and outdoor interiors, today announces that it has won the Best Online Business Award at the premier Scotlands Business Awards 2023.
- Best Online Business Award is a premier award to honor and recognize companies for their outstanding achievements and efforts in doing business online.
- Marco Paul received the prestigious Best Online Business Award for its massive performance in the business dimension.
- Scotlands Business Awards has recognized Marco Paul for its exceptional presentation in online business.
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
The poster entitled, “Relationship between N-acetylaspartate and neurofilament light chain in multiple system atrophy” was presented by Paula Trujillo Diaz, PhD, Research Assistant Professor, Department of Neurology, Vanderbilt University Medical Center.
- The poster entitled, “Relationship between N-acetylaspartate and neurofilament light chain in multiple system atrophy” was presented by Paula Trujillo Diaz, PhD, Research Assistant Professor, Department of Neurology, Vanderbilt University Medical Center.
- N-acetylaspartate (NAA) is a novel biomarker of neuronal integrity with potential for assessing disease severity, monitoring the course of disease, and evaluating the efficacy of disease modifying therapies in MSA.
- In the study, the data provided evidence that NAA correlates with levels of neurofilament light chain (NfL) in patients with early MSA.
- “The data presented at AAS reveals another potentially important biomarker for the evaluation of this rapidly progressive disease with no approved treatment.
EQS-News: Healthcare Specialist SHS Capital announces Final Closing of its oversubscribed Sixth Fund Generation totaling EUR 270 million
EUR 270 million and is more than doubling the predecessor fund’s size
- EUR 270 million and is more than doubling the predecessor fund’s size
SHS Capital has raised ca. - EUR 270 million for their sixth fund generation.
- Due to high demand, the originally targeted fund volume of EUR 200 million could significantly be exceeded and is thus more than double the predecessor fund’s size.
- Since the First Closing of the fund last summer, four investments have already been made from the new fund.
EQS-News: Healthcare specialist SHS Capital acquires Majority Stake in Life Science Robotics Company ESSERT
Founded in 2012, the company is a provider in the field of flexible robotics.
- Founded in 2012, the company is a provider in the field of flexible robotics.
- Right from the start, ESSERT strategically focused on production areas that are confronted with increasing product individualization.
- Renowned customers from the highly regulated pharmaceutical and life science industry have been trusting on ESSERT products for years.
- "ESSERT is a prime example of the focus of our newly launched SHS VI fund generation.
EQS-News: Healthcare Specialist SHS Capital acquires majority stake in CAM Bioceramics to support and accelerate its future growth
Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders
- Together with ING Corporate Investments and several Co-Investors, the German specialist healthcare investor acquires a majority stake in the company, while current owners remain significant shareholders
The German healthcare specialist SHS Capital, together with ING Corporate Investments and other Co-Investors, is investing in CAM Bioceramics, a contract development and manufacturing organisation (CDMO) for innovative orthobiological calcium phosphate solutions. - SHS invested in the company together with ING Corporate Investments (a 100% subsidiary of the renowned Dutch ING Bank) as well as several Co-Investors.
- "We are delighted to have SHS and ING Corporate Investments on board, hence enabling CAM Bioceramics to serve our customers even better and to grow even faster.
- The partnership with SHS and ING is a validation of our strategy and capabilities and will fuel the company’s growth even further.
EQS-News: Healthcare specialist SHS Capital sells Spiegelberg, a leading medtech expert for devices and consumables in the field of neurosurgery, to Luciole Medical
Healthcare specialist SHS Capital sells Spiegelberg, a leading medtech expert for devices and consumables in the field of neurosurgery, to Luciole Medical
- Healthcare specialist SHS Capital sells Spiegelberg, a leading medtech expert for devices and consumables in the field of neurosurgery, to Luciole Medical
The issuer is solely responsible for the content of this announcement. - Luciole Medical AG, which specialises in cerebral monitoring and measurement of oxygen saturation in the brain, is expanding its product range with the acquisition of Spiegelberg
German healthcare specialist SHS Capital is selling its shares in Spiegelberg to Luciole Medical AG. - Spiegelberg, a medical technology company based in Hamburg, develops, produces and distributes highly specialised catheters and measuring probes for neurosurgical applications in the brain.
- Founded in 1986, Spiegelberg has developed into a recognised provider in the field of intracranial pressure measurement.